Home › Neurologic Diseases › Texas › Houston
Neurologic Diseases clinical trials in Houston, TX
6 studies for Neurologic Diseases are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Houston, Texas, Houston
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Houston Methodist Hospital, Houston
- The University of Texas Health Science Center at Houston, Houston
Product Surveillance Registry
RecruitingObservational study
- Houston, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
Rett Syndrome Registry
RecruitingObservational study
- Texas Children's Hospital, Houston
Open-label Extension Study in Participants With Early Alzheimer's Disease
RecruitingPhase 2
- GSK Investigational Site, Houston
About Neurologic Diseases
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
More about Neurologic Diseases on MedlinePlus
Neurologic Diseases trials in other cities
- Boston, MA10 studies
- Washington, DC8 studies
- Miami, FL7 studies
- Philadelphia, PA7 studies
- Orlando, FL7 studies
- Dallas, TX7 studies
- St. Louis, MO6 studies
- San Diego, CA6 studies
- New York City, NY6 studies
- Chicago, IL6 studies
- Pittsburgh, PA5 studies
- Los Angeles, CA5 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.